FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP 1s : r tirzepatidecompound What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York US FDA to convene expert panel to review wider access to some peptides Reuters Valor Compounding Pharmacy Inc. Berkeley, CA. Untitled Letter issued 03 23 2023 Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed